Literature DB >> 2305041

In vitro radiosensitivity of human diploid fibroblasts derived from women with unusually sensitive clinical responses to definitive radiation therapy for breast cancer.

J S Loeffler1, J R Harris, W K Dahlberg, J B Little.   

Abstract

Between January 1985 and December 1986, 811 patients were treated for carcinoma of the breast at the Joint Center for Radiation Therapy by an identical protocol. Of these 811 patients, five patients (0.6%) were identified as having an unusually sensitive clinical response to routine external beam irradiation. This unusual clinical response was characterized by severe skin erythema and edema during the first few weeks of treatment, requiring treatment breaks. Skin fibroblast cell strains were established from these five women as well as from six women with a normal clinical response to breast irradiation (chosen at random from the population of 811 patients). Radiation survival parameters were determined by a colony formation assay from complete survival curves in coded and blinded samples. Cells from the sensitive patients were significantly more sensitive to the cytotoxic effects of radiation in vitro as determined by the parameters D0, D, D10, and n, than were the strains derived from patients with a normal response. We conclude that an unusually severe response to standard fractionated radiotherapy may be associated with greater intrinsic radiation sensitivity of the individual's somatic cells.

Entities:  

Mesh:

Year:  1990        PMID: 2305041

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  7 in total

Review 1.  Genetic and epigenetic features in radiation sensitivity. Part II: implications for clinical practice and radiation protection.

Authors:  Michel H Bourguignon; Pablo A Gisone; Maria R Perez; Severino Michelin; Diana Dubner; Marina Di Giorgio; Edgardo D Carosella
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03       Impact factor: 9.236

2.  [Genetic predisposition and radiation sensitivity of normal tissue].

Authors:  C Streffer
Journal:  Strahlenther Onkol       Date:  1997-09       Impact factor: 3.621

3.  In vitro prediction of breast cancer therapy toxicity.

Authors:  Michael J McKay; Jezzie Maneerat; Timothy M McKay; Jeremy N McKay; Reza Masoud-Rahbari
Journal:  Ann Transl Med       Date:  2017-03

Review 4.  Radiogenomics and radiotherapy response modeling.

Authors:  Issam El Naqa; Sarah L Kerns; James Coates; Yi Luo; Corey Speers; Catharine M L West; Barry S Rosenstein; Randall K Ten Haken
Journal:  Phys Med Biol       Date:  2017-08-01       Impact factor: 3.609

5.  Chromosomal in-vitro radiosensitivity of lymphocytes in radiotherapy patients and AT-homozygotes.

Authors:  J Dunst; S Neubauer; A Becker; E Gebhart
Journal:  Strahlenther Onkol       Date:  1998-10       Impact factor: 3.621

6.  The gangliosides as a possible molecular coupling factor between the proportion of radiosensitive cells in vitro and the metastatic potential in vivo within a human melanoma cell line.

Authors:  C P Thomas; A Buronfosse; J Portoukalian; B Fertil
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 7.  Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype.

Authors:  Gillian C Barnett; Catherine M L West; Alison M Dunning; Rebecca M Elliott; Charlotte E Coles; Paul D P Pharoah; Neil G Burnet
Journal:  Nat Rev Cancer       Date:  2009-01-16       Impact factor: 60.716

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.